Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jinan Limin Pharmaceutical is a Chinese pharmaceutical company based in Jinan, Shandong Province, and operates as a key subsidiary of the Qilu Pharmaceutical Group. The company specializes in the development, manufacture, and commercialization of finished dosage forms and active pharmaceutical ingredients (APIs), with a strong focus on cardiovascular, anti-infective, and gastrointestinal therapies. Its product portfolio includes widely used generic medications such as atorvastatin, enalapril, and various antibiotic formulations. Jinan Limin maintains large-scale manufacturing facilities that are GMP-certified, supporting both domestic supply in China and international exports. As part of the larger Qilu ecosystem, it plays a vital role in the group's production capacity and market reach for essential medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jinan Limin Pharmaceutical.